Zogenix, Inc. and Battelle Extend DosePro Co-Marketing Partnership
3/27/2013 10:52:52 AM
More...
|
Battelle and Zogenix, Inc. Release: Preliminary Findings From Rheumatoid Arthritis Patient Survey Reveal Strong Interest in Needle-Free Self-Injection
11/13/2012 8:32:30 AM
More...
|
Zogenix, Inc. and Battelle Launch "Less is More" DosePro® Marketing Campaign
7/30/2012 9:47:06 AM
More...
|
Battelle Wins $102 Million National Institute of Allergy And Infectious Diseases (NIAID) Biodefense Research Contract
7/18/2012 8:41:58 AM
More...
|
Biotechnology Industry Organization (BIO) and Battelle Release: Bioscience Industry Adds Jobs Over the Last Decade, Despite Economic Setbacks for the Nation
6/19/2012 9:56:42 AM
More...
|
Zogenix, Inc. and Battelle Ink Marketing Agreement for DosePro(R) Drug Delivery Technology
3/29/2012 10:01:42 AM
More...
|
Zogenix, Inc. and Battelle to Collaborate on Advanced Drug Delivery Technology
1/25/2012 9:31:26 AM
More...
|
Battelle Medical Device Expert Chad Bouton to Present at Independent Inventors Symposium
10/25/2011 11:37:27 AM
More...
|
Battelle's $200 Million Investment in Central Ohio Nearly Complete
9/16/2011 8:37:16 AM
More...
|
Battelle Places Order with Instem for Provantis Preclinical and submit-SEND Software Solutions
7/19/2011 8:29:08 AM
More...
|
|